Galectin Therapeutics, Inc. (GALT)

3.89 +0.18 (+4.85%) USD  |  NASDAQ  |  Sep 18, 16:00
3.89 0.00 (0.00%) After-Hours: 20:00
More

Galectin Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 14, 2026 --
June 23, 2026 --
May 28, 2026 --
May 15, 2026 --
March 31, 2026 --
March 11, 2026 --
December 19, 2025 --
December 17, 2025 --
November 14, 2025 --
Date Value
August 14, 2025 --
June 17, 2025 --
April 02, 2025 --
December 27, 2024 --
November 15, 2024 --
August 16, 2024 --
April 01, 2024 --
November 14, 2023 --
March 31, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Mirum Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade